Old Web
English
Sign In
Acemap
>
Paper
>
Targeted therapies: Selumetinib MEKing differences in NF1
Targeted therapies: Selumetinib MEKing differences in NF1
2017
Lisa Hutchinson
Keywords:
Immunology
CNS cancer
Oncology
Selumetinib
Internal medicine
Medicine
paediatric cancer
MEDLINE
Correction
Source
Cite
Save
Machine Reading By IdeaReader
1
References
6
Citations
NaN
KQI
[]